10x Genomics Share Price Today
(NASDAQ: TXG)

Name: 10x Genomics Share Price Today (NASDAQ: TXG) - 10x Genomics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

10x Genomics share price is $9.85 & ₹860.57 as on 4 Mar 2025, 2.30 'hrs' IST

$9.85

▲

-0.84

(-7.86%)

Market is closed - opens 8 PM, 04 Mar 2025

View live 10x Genomics share price in Dollar and Rupees. Guide to invest in 10x Genomics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in 10x Genomics, along with analyst recommendations, forecasts, and comprehensive financials.

10x Genomics share price movements

Today's Low: $9.79
Today's High: $10.70
$9.85
0.61%
Downside
Day's Volatility :8.5%
Upside
7.94%
52 Weeks Low: $9.85
52 Weeks High: $45.60
$9.85
0.0%
Downside
52 Weeks Volatility :78.4%
Upside
78.4%

10x Genomics (TXG) Returns

Period	10x Genomics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-32.43%	1.4%	0.0%
6 Months	-53.58%	-5.1%	0.0%
1 Year	-76.13%	1.8%	0.0%
3 Years	-84.4%	12.9%	-13.0%

10x Genomics (TXG) Key Statistics

in dollars & INR

Previous Close	$10.69
Open	$10.69
Today's High	$10.7
Today's Low	$9.79
Market Capitalization	$1.3B
Today's Volume	$2.9M
52 Week High	$45.6
52 Week Low	$9.79
Revenue TTM	$610.8M
EBITDA	$-156.6M
Earnings Per Share (EPS)	$-1.52
Profit Margin	-29.9%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-25.17%

How to invest in 10x Genomics Stock (TXG) from India?

It is very easy for Indian residents to invest directly in 10x Genomics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the 10x Genomics stock in both Indian Rupees (INR) and US Dollars (USD). Search for 10x Genomics or TXG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of 10x Genomics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of 10x Genomics shares which would translate to 0.089 fractional shares of 10x Genomics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like 10x Genomics, in just a few clicks!

Returns in 10x Genomics (TXG) for Indian investors in Rupees

The 10x Genomics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

10x Genomics investment value today

Current value as on today

₹27,424

Returns

₹72,576

(-72.58%)

Returns from 10x Genomics Stock

₹78,008 (-78.01%)

Dollar Returns

₹5,432 (+5.43%)

Indian investors sentiment towards 10x Genomics (TXG)

57.14%

Period: Feb 1, 2025 to Mar 3, 2025. Change in 30 Days versus previous period

Investment in 10x Genomics Shares from India has grown by 57.14% over the past 30 days, indicating increased transactional activity.

-13%

Period: Feb 1, 2025 to Mar 3, 2025. Change in 30 Days versus previous period

Search interest for 10x Genomics Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in 10x Genomics

FMR Inc
11.00%
ARK Investment Management LLC
9.77%
Vanguard Group Inc
8.94%
BlackRock Inc
5.54%
Sumitomo Mitsui Trust Group Inc
4.67%
Nikko Asset Management Americas Inc
4.67%

Analyst Recommendation on 10x Genomics

Buy

75%Buy

20%Hold

5%Sell

Based on 20 Wall street analysts offering stock ratings for 10x Genomics(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on 10x Genomics Stock (TXG)

What analysts predicted

Upside of 66.06%

Target:

$16.36

Current:

$9.85

Insights on 10x Genomics Stock (Ticker Symbol: TXG)

Price Movement
In the last 1 month, TXG stock has moved down by -26.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 151.65M → 165.02M (in $), with an average increase of 8.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -35.75M → -49.02M (in $), with an average decrease of 37.1% per quarter
TXG vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 151.3% return, outperforming this stock by 227.8%
TXG vs HQY (3 yr)
In the last 3 years, Healthequity Inc has given 24.2% return, outperforming this stock by 109.8%
Price to Sales
ForTXG every $1 of sales, investors are willing to pay $2.1, whereas for Doximity, Inc., the investors are paying $23.9 for every $1 of sales.

TXG 10x Genomics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$245.9M	↑ 68.06%
Net Income	$-31.3M	↓ 72.22%
Net Profit Margin	-12.71%	↑ 64.17%

	FY20	Y/Y Change
Revenue	$298.8M	↑ 21.53%
Net Income	$-542.7M	↑ 1636.68%
Net Profit Margin	-181.61%	↓ 168.9%

	FY21	Y/Y Change
Revenue	$490.5M	↑ 64.13%
Net Income	$-58.2M	↓ 89.27%
Net Profit Margin	-11.87%	↑ 169.74%

	FY22	Y/Y Change
Revenue	$516.4M	↑ 5.28%
Net Income	$-166.0M	↑ 185.11%
Net Profit Margin	-32.15%	↓ 20.28%

	FY23	Y/Y Change
Revenue	$618.7M	↑ 19.81%
Net Income	$-255.1M	↑ 53.67%
Net Profit Margin	-41.23%	↓ 9.08%

	FY24	Y/Y Change
Revenue	$610.8M	↓ 1.28%
Net Income	$-182.6M	↓ 28.41%
Net Profit Margin	-29.9%	↑ 11.33%

	Q3 FY23	Q/Q Change
Revenue	$153.6M	↑ 4.65%
Net Income	$-93.0M	↑ 48.98%
Net Profit Margin	-60.52%	↓ 18.01%

	Q4 FY23	Q/Q Change
Revenue	$184.0M	↑ 19.74%
Net Income	$-49.0M	↓ 47.36%
Net Profit Margin	-26.61%	↑ 33.91%

	Q1 FY24	Q/Q Change
Revenue	$141.0M	↓ 23.36%
Net Income	$-59.9M	↑ 22.46%
Net Profit Margin	-42.52%	↓ 15.91%

	Q2 FY24	Q/Q Change
Revenue	$153.1M	↑ 8.58%
Net Income	$-37.9M	↓ 36.78%
Net Profit Margin	-24.75%	↑ 17.77%

	Q3 FY24	Q/Q Change
Revenue	$151.7M	↓ 0.95%
Net Income	$-35.8M	↓ 5.66%
Net Profit Margin	-23.58%	↑ 1.17%

	Q4 FY24	Q/Q Change
Revenue	$165.0M	↑ 8.81%
Net Income	$-49.0M	↑ 37.13%
Net Profit Margin	-29.71%	↓ 6.13%

	FY19	Y/Y Change
Profit	$184.9M	↑ 57.12%

	FY20	Y/Y Change
Profit	$240.4M	↑ 30.03%

	FY21	Y/Y Change
Profit	$416.4M	↑ 73.23%

	FY22	Y/Y Change
Profit	$396.0M	↓ 4.89%

	FY23	Y/Y Change
Profit	$409.3M	↑ 3.36%

	FY24	Y/Y Change
Profit	$414.5M	↑ 1.26%

	Q3 FY23	Q/Q Change
Profit	$95.5M	↓ 4.1%

	Q4 FY23	Q/Q Change
Profit	$106.1M	↑ 11.03%

	Q1 FY24	Q/Q Change
Profit	$95.6M	↓ 9.9%

	Q2 FY24	Q/Q Change
Profit	$106.9M	↑ 11.85%

	Q3 FY24	Q/Q Change
Profit	$106.4M	↓ 0.47%

	Q4 FY24	Q/Q Change
Profit	$111.0M	↑ 4.29%

	FY19	Y/Y Change
Operating Cash Flow	$34.6M	↓ 145.32%
Investing Cash Flow	$-42.8M	↑ 537.46%
Financing Cash Flow	$414.6M	↑ 293.47%

	FY20	Y/Y Change
Operating Cash Flow	$-217.9M	↓ 729.27%
Investing Cash Flow	$-38.4M	↓ 10.23%
Financing Cash Flow	$468.9M	↑ 13.1%

	FY21	Y/Y Change
Operating Cash Flow	$-21.4M	↓ 90.19%
Investing Cash Flow	$-106.7M	↑ 177.98%
Financing Cash Flow	$35.3M	↓ 92.47%

	FY22	Y/Y Change
Operating Cash Flow	$-33.6M	↑ 57.24%
Investing Cash Flow	$-350.9M	↑ 228.76%
Financing Cash Flow	$15.8M	↓ 55.19%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-25.3M	↑ 119.54%
Investing Cash Flow	$4.9M	↓ 209.82%
Financing Cash Flow	$4.4M	↓ 38.36%

10x Genomics Technicals Summary

Sell

Neutral

Buy

10x Genomics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

10x Genomics (TXG) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
10x Genomics Inc	-26.02%	-53.58%	-76.13%	-84.4%	-85.27%
Doximity, Inc.	19.29%	96.38%	146.25%	34.83%	33.02%
Solventum Corp	8.39%	24.94%	15.41%	15.41%	15.41%
Ge Healthcare Technologies Inc.	-0.18%	3.01%	-5.8%	44.4%	44.4%
Veeva Systems Inc.	-3.92%	3.89%	-0.82%	23.49%	52.95%
Healthequity Inc	-0.5%	39.59%	33.24%	114.88%	65.08%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
10x Genomics Inc	NA	NA	NA	-0.53	-0.25	-0.13	NA	5.81
Doximity, Inc.	69.45	69.45	3.75	1.31	0.21	0.13	NA	5.5
Solventum Corp	198.16	198.16	NA	6.57	0.1	0.06	NA	18.48
Ge Healthcare Technologies Inc.	20.13	20.13	2.29	4.68	0.26	0.06	0.0	18.48
Veeva Systems Inc.	54.7	54.7	1.27	6.45	0.13	0.07	NA	33.93
Healthequity Inc	98.17	98.17	1.16	3.15	0.05	0.04	NA	24.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
10x Genomics Inc	Buy	$1.3B	-85.27%	NA	-29.9%
Doximity, Inc.	Hold	$13.0B	33.02%	69.45	36.6%
Solventum Corp	Hold	$13.0B	15.41%	198.16	8.76%
Ge Healthcare Technologies Inc.	Buy	$39.9B	44.4%	20.13	10.13%
Veeva Systems Inc.	Buy	$35.9B	52.95%	54.7	25.07%
Healthequity Inc	Buy	$9.3B	65.08%	98.17	8.41%

10x Genomics Dividend announcements

10x Genomics Earnings
10x Genomics’s price-to-earnings ratio stands at None
Read More

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Organization	10x Genomics
Employees	1306
CEO	Dr. Serge Saxonov Ph.D.
Industry	Commercial Services

Management People of 10x Genomics

Name	Title
Dr. Serge Saxonov Ph.D.	Co-Founder, CEO & Director
Dr. Benjamin J. Hindson Ph.D.	Co-Founder, President, Chief Scientific Officer & Director
Mr. Eric S. Whitaker Esq.	Chief Legal Officer
Mr. Adam S. Taich	CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
Mr. Jim Goodrich	Chief of Global Operations
Mr. Michael Schnall-Levin	Founding Scientist & CTO
Mr. Alexander Wong	Chief Information Officer
Ms. Cassie Corneau	Manager of Investor Relations & Strategic Finance
Ms. Rebecca Port	Chief People Officer
Ms. Mennah Moustafa	Chief Commercial Officer

Important FAQs about investing in TXG Stock from India :

What is 10x Genomics share price today?

10x Genomics share price today stands at $9.85, Open: $10.69 ; Previous Close: $10.69 ; High: $10.70 ; Low: $9.79 ; 52 Week High: $45.60 ; 52 Week Low: $9.85.

The stock opens at $10.69, after a previous close of $10.69. The stock reached a daily high of $10.70 and a low of $9.79, with a 52-week high of $45.60 and a 52-week low of $9.85.

Can Indians buy 10x Genomics shares?

Yes, Indians can invest in the 10x Genomics (TXG) from India.

With INDmoney, you can buy 10x Genomics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy 10x Genomics at zero transaction cost.

How can I buy 10x Genomics shares from India?

It is very easy to buy 10x Genomics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of 10x Genomics (TXG) be purchased?

Yes, you can buy fractional shares of 10x Genomics with INDmoney app.

What are the documents required to start investing in 10x Genomics stocks?

To start investing in 10x Genomics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.